Virtu Financial’s Onconetix ONCO Stock Holding History

Virtu Financial’s Portfolio ONCO Stock Details ONCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$2K	–	1882
2025 Q1	$2K	Buy	+5	New	+$8.58K	﹤0.01%	1253
2024 Q2	–	Hold	0	–	-$4K	–	1727
2024 Q1	–	Hold	0	–	–	–	1300
2023 Q4	–	Hold	0	–	–	–	1488
2023 Q3	–	Hold	0	–	–	–	1044
2023 Q2	–	Hold	0	–	–	–	1291
2023 Q1	–	Hold	0	–	-$18K	–	1937
2022 Q4	–	Hold	0	–	–	–	1290
2022 Q3	–	Hold	0	–	-$52K	–	2093
2022 Q2	–	Hold	0	–	–	–	1116

Other funds holding ONCO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Virtu Financial's ONCO Position: Q2 2025 in Review

Virtu Financial sold out of Onconetix (ONCO) in Q2 2025, closing a stake of 5 shares — an estimated $2K sold.

Virtu Financial first reported a position in ONCO in Q1 2025 and held it in 1 quarter. The position peaked at $2K in Q1 2025. 5 funds tracked by Wall St. Rank hold ONCO as of Q2 2025.

Virtu Financial reported no remaining Onconetix position as of Q2 2025 after selling out during the quarter.
Virtu Financial sold 5 Onconetix shares in Q2 2025, an estimated $2K.
Virtu Financial first reported a position in Onconetix in Q1 2025 and held it in 1 quarter.
Virtu Financial's Onconetix position peaked at $2K in Q1 2025.
5 funds tracked by Wall St. Rank held Onconetix as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.